1. Andersen PH, Grønvald FC, Hohlweg R, Hansen LB, Guddal E, Braestrup C, Nielsen EB (1992) NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists. Eur J Pharmacol 219:45–52
2. Casey DE (1988) Tardive dyskinesia and dopamine receptor hypersensitivity: pros and cons. In: Belmaker RH, Sandler M, Dahlström (eds) Neurology and neurobiology (vol 42C), progress in catecholamine research, part C: clinical aspects. Alan R. Liss, New York, pp 9–12
3. Casey DE (1989a) Clozapine: neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology 99:S47-S53
4. Casey DE (1989b) Serotonergic aspects of acute extrapyramidal syndromes in nonhuman primates. Psychopharmacol Bull 25:457–459
5. Casey DE (1991a) Extrapyramidal syndromes in nonhuman primates: typical and atypical neuroleptics. Psychopharmacol Bull 27:47–50